Últimas noticias sobre Udemy (NASDAQ:UDMY) Bolsa

Udemy

Udemy Inc operates a marketplace platform at the center of a vibrant knowledge network. The company operates under two operating and reportable segments Consumer and Enterprise, out of which the Enterprise segment derives the maximum revenue. Geographically, the company derives maximum revenue from North America. The company leverages data, technology, and insights for effective learning experiences. It helps individuals and organizations to possess effective skill acquisition and development with flexibility.

Udemy Inc

UBS analyst Thomas Wadewitz maintains Saia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIA#NASDAQ">SAIA</a>) with a Buy and lowers the price target from $422 to $305.

News

Price Target

Analyst Ratings

SAIA

UBS Maintains Buy on Saia, Lowers Price Target to $305

National Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRC#NASDAQ">NRC</a>) reported quarterly earnings of $0.25 per share. This is a 7.41 percent decrease over earnings of $0.27 per share from the same period last year. The company reported $33.55 million in sales this quarter. This is a 4.99 percent decrease over sales of $35.31 million the same period last year.

Earnings

National Research Q1 EPS $0.25 Down From $0.27 YoY, Revenue $33.55M Down From $35.31M YoY

NOV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>) reported quarterly earnings of $0.19 per share which missed the analyst consensus estimate of $0.26 by 26.92 percent. This is a 36.67 percent decrease over earnings of $0.30 per share from the same period last year. The company reported quarterly sales of $2.10 billion which met the analyst consensus estimate. This is a 2.41 percent decrease over sales of $2.15 billion the same period last year.

Earnings Misses

NOV Q1 EPS $0.19 Misses $0.26 Estimate, Sales $2.10B Inline

UBS analyst Dennis Geiger maintains Starbucks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) with a Neutral and lowers the price target from $105 to $90.

SBUX

UBS Maintains Neutral on Starbucks, Lowers Price Target to $90

Krystal Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRYS#NASDAQ">KRYS</a>) has outperformed the market over the past 5 years by 15.4% on an annualized basis producing an average annual return of 29.66%. Currently, Krystal Biotech has a market capitalization of $4.89 billion. 
Buying $100 In KRYS: If an investor had bought $100 of KRYS stock 5 years ago, it would be worth $359.67 today based on a price of $169.73 for KRYS at the time of writing.
<h3>Krystal Biotech's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745876711_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

KRYS

Here's How Much You Would Have Made Owning Krystal Biotech Stock In The Last 5 Years

UBS analyst Lloyd Walmsley maintains Booking Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKNG#NASDAQ">BKNG</a>) with a Buy and lowers the price target from $5960 to $5557.

BKNG

UBS Maintains Buy on Booking Holdings, Lowers Price Target to $5557

Teradyne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>) is looking for Q2 GAAP EPS of $0.35-$0.48 vs $0.51 analyst estimate..

Guidance

Teradyne Sees Q2 GAAP EPS $0.35-$0.48 vs $0.51 Est

UBS analyst Jay Sole maintains Carter's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRI#NYSE">CRI</a>) with a Neutral and lowers the price target from $37 to $32.

UBS Maintains Neutral on Carter's, Lowers Price Target to $32

<a href="https://www.bloomberg.com/news/articles/2025-04-28/boeing-removed-from-credit-watch-by-s-p-in-turnaround-boost?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-04-28/boeing-removed-from-credit-watch-by-s-p-in-turnaround-boost?embedded-checkout=true</a>

General

'Boeing Removed From Credit Watch by S&P in Turnaround Boost'- Bloomberg

UBS analyst Stephen Ju maintains Expedia Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPE#NASDAQ">EXPE</a>) with a Neutral and lowers the price target from $194 to $170.

EXPE

UBS Maintains Neutral on Expedia Group, Lowers Price Target to $170

German American Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GABC#NASDAQ">GABC</a>) reported quarterly earnings of $0.79 per share which beat the analyst consensus estimate of $0.66 by 19.7 percent. This is a 27.42 percent increase over earnings of $0.62 per share from the same period last year. The company reported quarterly sales of $81.41 million which beat the analyst consensus estimate of $79.56 million by 2.33 percent. This is a 33.87 percent increase over sales of $60.82 million the same period last year.

Earnings Beats

GABC

German American Bancorp Q1 Adj. EPS $0.79 Beats $0.66 Estimate, Sales $81.41M Beat $79.56M Estimate

UBS analyst Brian Meredith maintains Goosehead Insurance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSHD#NASDAQ">GSHD</a>) with a Buy and lowers the price target from $145 to $140.

GSHD

UBS Maintains Buy on Goosehead Insurance, Lowers Price Target to $140

UBS analyst Ashwani Verma maintains Harmony Biosciences Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRMY#NASDAQ">HRMY</a>) with a Buy and lowers the price target from $55 to $48.

HRMY

UBS Maintains Buy on Harmony Biosciences Hldgs, Lowers Price Target to $48

Linkbancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNKB#NASDAQ">LNKB</a>) reported quarterly earnings of $0.20 per share which missed the analyst consensus estimate of $0.24 by 16.67 percent. This is a 25 percent increase over earnings of $0.16 per share from the same period last year. The company reported quarterly sales of $39.09 million which beat the analyst consensus estimate of $32.48 million by 20.34 percent. This is a 46.88 percent increase over sales of $26.61 million the same period last year.

LNKB

Linkbancorp Q1 Adj. EPS $0.20 Misses $0.24 Estimate, Sales $39.09M Beat $32.48M Estimate

UBS analyst Stephen Ju maintains Airbnb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>) with a Neutral and lowers the price target from $160 to $138.

ABNB

UBS Maintains Neutral on Airbnb, Lowers Price Target to $138

Broadway Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYFC#NASDAQ">BYFC</a>) reported quarterly losses of $(0.14) per share. This is a 600 percent decrease over losses of $(0.02) per share from the same period last year. The company reported $8.33 million in sales this quarter. This is a 6.42 percent increase over sales of $7.83 million the same period last year.

BYFC

Broadway Financial Q1 EPS $(0.14) Down From $(0.02) YoY, Sales $8.33M Up From $7.83M YoY

UBS analyst Ashwani Verma maintains ACADIA Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACAD#NASDAQ">ACAD</a>) with a Buy and lowers the price target from $25 to $22.

ACAD

UBS Maintains Buy on ACADIA Pharmaceuticals, Lowers Price Target to $22

UBS analyst Ashwani Verma maintains Alkermes (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALKS#NASDAQ">ALKS</a>) with a Neutral and lowers the price target from $38 to $33.

ALKS

UBS Maintains Neutral on Alkermes, Lowers Price Target to $33

WIIM

OKTA

Okta shares are trading higher after the company announced it will replace Berry Global Group in the S&P Midcap 400, effective before the opening of trading on Thursday, May 1

<a href="https://www.bloomberg.com/news/articles/2025-04-28/alibaba-rolls-out-latest-flagship-ai-model-in-post-deepseek-race">https://www.bloomberg.com/news/articles/2025-04-28/alibaba-rolls-out-latest-flagship-ai-model-in-post-deepseek-race</a>

BABA

'Alibaba Rolls Out Latest Flagship AI Model in Post-DeepSeek Race'- Bloomberg

Press Releases

Udemy's Annual Report Finds Enterprises Are Leveraging GenAI to Maximize Productivity and Unblock Human-Powered Upskilling

Udemy Appoints Marylou Maco and Debra Chrapaty to its Board of Directors

Udemy to Present at Needham's 27th Annual Growth Conference

Udemy to Announce Fourth Quarter and Full Year 2024 Results on February 13

Udemy Reports Fourth Quarter and Full Year 2024 Results

Entertainment

WENDY, CHICAGO-BASED STARTUP, LAUNCHES AI STORY-BUILDING TOOLBOX FOR KIDS

Udemy Appoints Hugo Sarrazin as Chief Executive Officer

Udemy Recognized as a Strategic Leader in 2025 Fosway 9-Grid™ for Outcomes-Driven Skills Development Solutions

Udemy to Announce First Quarter 2025 Results on April 30

Udemy Appoints Neeracha Taychakhoonavudh as Chief Customer Experience Officer to Accelerate Enterprise Strategy

FVRR

GRPN

UDMY

Afya

American Public Education, Inc. - Common Stock

American Public Education

Adtalem Global Education Inc. Common Stock

Adtalem Glb Education

Bright Horizons Family Solutions Inc. Common Stock

Bright Horizons Family

China Liberal Education Holdings Limited - Ordinary Shares

China Liberal Education

Coursera

Youdao, Inc. American Depositary Shares, each representing one Class A Ordinary Share

Youdao

Duolingo

New Oriental Education & Technology Group, Inc. Sponsored ADR representing 10 Ordinary Share (Cayman Islands)

New Oriental Education

Graham Hldgs

Gaotu Techedu Inc. American Depositary Shares

Gaotu Techedu

KinderCare Learning Companies, Inc. Common Stock

KinderCare Learning

Laureate Education

Lincoln Educational Services Corporation - Common Stock

Lincoln Educational Servs

Grand Canyon Education, Inc. - Common Stock

Grand Canyon Education

Stride

NETCLASS TECHNOLOGY INC - Class A Ordinary Shares

Netclass Technology

Perdoceo Education Corporation - Common Stock

Perdoceo Education

Pearson

QuantaSing Group Limited - American Depositary Shares

QuantaSing Group

Strategic Education

TAL Education Group American Depositary Shares

TAL Education

Universal Technical Institute Inc Common Stock

Universal Technical

Vasta Platform Limited - Class A Ordinary Shares

Comments

Udemy

Noticias

Últimas noticias sobre Udemy (NASDAQ:UDMY) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL